Some roundup plaintiffs seek to delay preliminary approval of proposed USD 7.25bln Bayer (BAYN GY) settlement

The request from some plaintiffs to delay the preliminary approval of Bayer's substantial settlement could introduce uncertainty around the company’s legal liabilities and financial outlook.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Anthropic acquires Vercept to advance Claude's computer use capabilities; Vercept will wind down its external product in coming weeks & join Anthropic in pushing frontiers of computer use

Newsquawk Daily US Earnings Estimates - 26th February 2026: INTU, DELL, MNST

Some roundup plaintiffs seek to delay preliminary approval of proposed USD 7.25bln Bayer (BAYN GY) settlement

US sells 17-week bills at high rate 3.590%, B/C 3.20x

US sells USD 28bln of 2-year FRNs at a high discount margin of 0.099%

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This might lead to volatility in Bayer's shares and could also impact related sectors, particularly pharmaceuticals and equities more broadly. Traders should watch for reactions in both the stock's price and potential shifts in market sentiment related to the broader litigation climate.

Related headlines

The whole workspace, free to try.

Try it free